State Key Laboratory of Drug Research (SKLDR), which was approved by Chinese Academy of Sciences under the unremitting efforts of reorganizing the state key laboratory system, is recruiting a Deputy Director. The candidate is expected to help SKLDR to continuously improve the academic influence and the ability to transform new drug achievements into real productivity.
Trending - Altmetric
Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies
Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19
Amyloid beta: structure, biology and structure-based therapeutic development
Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients